Bortezomib Sun
Analogs of Bortezomib Sun
Find cheaper analogs and generic equivalents for Bortezomib Sun.
Active Ingredient: bortezomib
Product Overview
About Bortezomib Sun
Bortezomib Sun is a cancer medicine.
What it is used for
Bortezomib Sun is used to treat multiple myeloma, a blood cancer, in the following groups of patients:
- Adults whose disease is getting worse after at least one other treatment and who have already had, or cannot undergo, blood stem-cell transplantation.
- Previously untreated adults who cannot have high-dose chemotherapy with blood stem-cell transplantation.
- Previously untreated adults who are going to receive high-dose chemotherapy followed by blood stem-cell transplantation.
- Untreated adults who cannot have blood stem-cell transplantation and have mantle cell lymphoma, another blood cancer.
How it is used
The medicine can only be obtained with a prescription and treatment should only be started and given under the supervision of a doctor who has experience in the use of cancer chemotherapy.
Bortezomib Sun is available in vials as a 3.5 mg powder to be made up into a solution for injection into a vein or under the skin.
At least 72 hours must pass between two doses of Bortezomib Sun.
Doses of Bortezomib Sun are given with rest periods between doses, in treatment cycles of three to six weeks depending on whether Bortezomib Sun is given alone or in combination with other medicines.
How it works
The active substance in Bortezomib Sun, bortezomib, is a proteasome inhibitor.
It blocks proteasome, which is a system in cells that breaks down proteins that are no longer needed.
Blocking the proteasome system causes the cell to die.
Cancer cells are more sensitive than normal cells to the effects of proteasome inhibitors like bortezomib.
Active substance: bortezomib
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
